Navigation Links
UofL's Ruth Carrico selected for National Nurse Fellowship
Date:8/16/2011

ated at the Center for Creative Leadership (CCL), and co-directed by: Linda Cronenwett, Ph.D., R.N., F.A.A.N., the Beerstecher Blackwell Term Professor and former dean of the School of Nursing at the University of North Carolina at Chapel Hill; and David Altman, executive vice president of Research, Innovation and Product Development at CCL.

"The Institute of Medicine report on the Future of Nursing, issued last fall, underscores the importance of nurse leadership as we work to improve the health and health care of all Americans," Cronenwett said. "The RWJF Executive Nurse Fellows program is building and enhancing the leadership skills of extraordinary nurses around the country. Our alumni are a virtual 'who's who' of accomplished nurses, and we know that Ruth Carrico and the other members of this new cohort will join them in doing great things. The RWJF Executive Nurse Fellows program supports nurse leaders with potential to develop innovative ways to improve health care delivery."

"I'm thrilled by the opportunity that the Executive Nurse Fellows program offers to build my advanced leadership skills," Carrico said. "Nursing practice is critical to addressing the problem of health care-associated infections, so I hope to have the chance to consider educational curricula and possible improvement opportunities. Participation in the program represents a once in a lifetime opportunity for leadership development."

Executive Nurse Fellows hold senior leadership positions in health services, scientific and academic organizations, public health and community-based organizations or systems, and national professional, governmental and policy organizations. They continue in their current positions during their fellowships, and during the fellowship each develops, plans and implements a new initiative to improve health care delivery in her or his community. Carrico plans to focus her initiative on health care-associated infections.

In addit
'/>"/>

Contact: Julie Heflin
julie.heflin@louisville.edu
502-852-7987
University of Louisville
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Nurse-Attorney/Former Bristol-Myers Squibb Executive Selected To Lead New Jersey State Nurses Association
2. Keenan Chief Strategy Officer Selected to Join Editorial Board of Payers & Providers
3. The Icebox of Atlanta Selected as T-shirt Vendor for 3 Major Divisions of American Cancer Society's Relay For Life
4. Nurtur Is Selected By Keenan & Associates as Exclusive Provider of Disease Management Programs
5. Small Time Company Rolls into the Big League: Trigger Point Performance Therapy Selected to Attend Athletes' Performance NFL Combine Preparation Program
6. Rajesh Khanna, MD Selected as One of America's Top Ophthalmologist
7. DC Dermatologist Dr. Susan T. Elliott Selected Best Doctor by Washingtonian Magazine
8. PrescriptionDrugs.com and Mike “Zappy” Zapolin Have Been Selected to Compete in Harvard Business School New Venture Contest
9. Dr. Rajesh Khanna Selected as Best Lasik Surgeon Two Years in a Row
10. R. Shane Jackson Selected as Panelist for Center for Health Transformation Member Meeting
11. Phoseon Technology Selected as Finalist for 2010 TechAmerica Oregon Technology Awards
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2015)... Vancouver, BC (PRWEB) April 28, 2015 ... published a blog stating that it is smarter to ... of a personal injury claim. The blog reasons that ... lawyer since these professional are well-versed with the law ... the client would be able to on their own. ...
(Date:4/28/2015)... City, Missouri (PRWEB) April 28, 2015 ... by the American Museum of Natural History, will open ... spring 2016, supported by sponsorship from Saint Luke’s Health ... New York City, Toronto, Granada and Milan, this one-of-a-kind ... about science and technology. , “Saint Luke’s and ...
(Date:4/28/2015)... Chicago, IL (PRWEB) April 28, 2015 ... enhance its research and healthcare services programs, the ... Orlando, Ph.D. Orlando comes to MDA from Fidelity ... oversaw funding of research projects in neurodegenerative diseases ... scientific conferences. Prior to her time at Fidelity, ...
(Date:4/28/2015)... Colorado (PRWEB) April 28, 2015 Colorado ... an updated version of his popular spine education website ... ASKSPINEDOC.COM developed by eMedical Media. This website has ... of the anatomy of the spine, causes of neck ... Dr. Corenman created this website and personally answers questions ...
(Date:4/28/2015)... OsteoRemedies®, LLC, Memphis, TN, offers the ... infected hip and knee arthroplasty. , ... pre-loaded spacer with Gentamicin Antibiotics, for consistent and ... Combined with a consistent process for polishing the ... for temporary use for up to 180 days. ...
Breaking Medicine News(10 mins):Health News:Vancouver Personal Injury Lawyers Recently Stated in Latest Blog That It Is Smarter To Call A Lawyer Before ICBC 2Health News:Saint Luke's Health System to sponsor Brain: The Inside Story exhibition at Museum at Prairiefire 2Health News:MDA Adds Neurological Disease Expert to Research Team 2Health News:MDA Adds Neurological Disease Expert to Research Team 3Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 2Health News:Colorado Spine Surgeon Donald Corenman, MD, DC Launches Updated Version of NECKANDBACK.COM and Popular Back Pain Forum ASKSPINEDOC.COM 3
... debilitating headaches , , THURSDAY, Feb. 12 (HealthDay News) -- Being ... and middle-aged adults, suggests a U.S. study that included 22,211 ... was distributed affected migraine risk. People ages 20 to 55 ... than those with smaller waistlines. , Migraine was reported by ...
... By The Bay, a regional resource for hospice ... end-of-life care at no charge to all healthcare ... starting in March. CEUs are available. The ongoing ... held in Larkspur. For the schedule of trainings, ...
... MINNEAPOLIS, Feb. 12 Biotel Inc.,(OTC Bulletin Board: BTEL) ... with net earnings of $289,000, or $0.10 per diluted ... of $206,000, or $0.07,per diluted share, on revenues of ... six months ended December 31, 2008, Biotel had net ...
... The Disabled American Veterans today applauds the introduction ... predictable funding for veterans health care and an ... budget process."The Veterans Health Care Budget Reform and ... efficient, transparent and accountable. These are three key ...
... the government,s vaccine program," says SafeMinds.WASHINGTON, Feb. 12 ... three families who argued that vaccination contributed to their ... on inadequate vaccine safety science available to the court. ... the defendant in "vaccine court" and is also responsible ...
... Arrow Group, a New York-based full-service strategic consulting ... Schweinitz has joined the company.As a member of ... be responsible for driving business growth by ensuring ... expanding Big Arrow,s offerings and expertise, especially in ...
Cached Medicine News:Health News:Belly Fat May Make Migraines More Likely 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 2Health News:Hospice By The Bay Offers Health Care Professionals Free Training in End-of-Life Care 3Health News:Biotel Announces Profitable Second Quarter Ended December 31, 2008 2Health News:Veterans Health Care Funding Reform Bill Promises Transparency, Accountability 2Health News:Veterans Health Care Funding Reform Bill Promises Transparency, Accountability 3Health News:Federal Vaccine Court Rulings Against Autism Families Due to Government's Refusal to Fund Sound Science 2Health News:Big Arrow Group Expands Global Capabilities with Addition of Anne de Schweinitz 2
(Date:4/28/2015)...  Boston Scientific Corporation (NYSE: BSX ) ... quarter ended March 31, 2015, compared to the ... to $1.800 billion.  This represents 6 percent operational ... and flat revenue on a reported basis, all ... achieved adjusted earnings per share of $0.21 for ...
(Date:4/28/2015)... PARSIPPANY, N.J. and INDIANAPOLIS , ... who undergo an angioplasty procedure and receive a heart stent ... help prevent a heart attack, a blood clot in their ... survey conducted by Harris Poll found that 52 percent of ... missed taking or changed the way they take their prescribed ...
(Date:4/28/2015)... April 28, 2015  Shares of Celladon Corp. (NASDAQ: ... yesterday following the announcement of poor drug trial results of ... gene therapy agent, MYDICAR.  The selloff may be warranted ... company at bargain basement prices. An analyst ... overview, current pipeline, financial review, analyst summary, valuation, and ...
Breaking Medicine Technology:Boston Scientific Announces Results for First Quarter 2015 2Boston Scientific Announces Results for First Quarter 2015 3Boston Scientific Announces Results for First Quarter 2015 4Boston Scientific Announces Results for First Quarter 2015 5Boston Scientific Announces Results for First Quarter 2015 6Boston Scientific Announces Results for First Quarter 2015 7Boston Scientific Announces Results for First Quarter 2015 8Boston Scientific Announces Results for First Quarter 2015 9Boston Scientific Announces Results for First Quarter 2015 10Boston Scientific Announces Results for First Quarter 2015 11Boston Scientific Announces Results for First Quarter 2015 12Boston Scientific Announces Results for First Quarter 2015 13Boston Scientific Announces Results for First Quarter 2015 14Boston Scientific Announces Results for First Quarter 2015 15Boston Scientific Announces Results for First Quarter 2015 16Boston Scientific Announces Results for First Quarter 2015 17Boston Scientific Announces Results for First Quarter 2015 18Boston Scientific Announces Results for First Quarter 2015 19Boston Scientific Announces Results for First Quarter 2015 20Boston Scientific Announces Results for First Quarter 2015 21Boston Scientific Announces Results for First Quarter 2015 22Boston Scientific Announces Results for First Quarter 2015 23Boston Scientific Announces Results for First Quarter 2015 24Boston Scientific Announces Results for First Quarter 2015 25Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 2Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 3Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 4Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 5Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 6Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 7Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 8Survey Finds Half of Heart Stent Patients Don't Take Their Oral Antiplatelet Medication As Prescribed 9Examining what's Left after MYDICAR Drug Trial Ends In Failure; Celladon Corp. Analyst Report Issued by BrokerBank Securities, Inc. 2
... Knopp Neurosciences Inc. ("Knopp"),announced that the U.S. ... Development has granted orphan drug designation to ... (ALS). (Logo: http://www.newscom.com/cgi-bin/prnh/20070924/KNOPPLOGO ) ... studies to evaluate the safety,tolerability and pharmacokinetics ...
... on stringent endpoint of clinical ... PHILADELPHIA, Oct. 15 An analysis of data to,be ... Scientific Meeting found that Asacol, dosed at 2.4 g/day, ... active,ulcerative colitis (UC). The analysis was based on data ...
Cached Medicine Technology:Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 2New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 3New Analysis of Study Data Shows That Asacol(R) (Mesalamine) Delivers Rapid Symptom Relief for Ulcerative Colitis Patients 4
... Insta Test is an immunochromatography ... It is designed for qualitative ... specimens. The presence of myoglobin ... or higher can be detected ...
This advanced digital monitor detects the appearance of an irregular heartbeat during measurement and gives a warning signal with your reading. An irregular heartbeat may cause or indicate cardiovasc...
... (PSA) is a serine protease that is found ... of the acini and ducts. Normal PSA concentration ... Reports have suggested that elevated level of whole ... tumor markers in diagnosis of prostate cancers. InstaTest ...
... 25-Hydroxyvitamin D Assay is for use only ... Nichols Advantage® 25-Hydroxyvitamin D Assay is intended ... (25-OH-D) and other hydroxylated metabolites of vitamin ... used as an aid in the assessment ...
Medicine Products: